NCT01477346已完成不适用
Arthritis Research UK Gout Treatment Trial. Phase 2: Two Year Randomised Controlled Trial of a Nurse Led Package of Care
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 517
- 试验地点
- 2
- 主要终点
- Reduction in serum uric acid levels
研究概览
简要总结
The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of gout
- •At least one acute attack of gout within previous 12 months
排除标准
- •Inability to give informed consent and known terminal or mental illness
结局指标
主要结局
Reduction in serum uric acid levels
时间窗: 2 years
次要结局
- Improved Quality of Life scores at study end(2 years)
- Reduction in number of self reported acute attacks during year 2(2 years)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
4 期
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutGoutNCT04875702Massachusetts General Hospital650
已完成
3 期
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)Arthritis, GoutyGout ChronicGoutHyperuricemiaNCT06439602Arthrosi Therapeutics818
已完成
4 期
RESTART C0168Z05 Rheumatoid Arthritis StudyRheumatoid ArthritisNCT00714493Centocor Ortho Biotech Services, L.L.C.203
已完成
4 期
Objective Study in Rheumatoid ArthritisArthritis, RheumatoidNCT00451971Sanofi249
已完成
3 期
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)Cardiovascular DiseaseNCT01101035Takeda6,198